![](/img/cover-not-exists.png)
Phase II Study of Risk-Adapted Therapy of Newly Diagnosed, Aggressive Non-Hodgkin Lymphoma Based on Midtreatment FDG-PET Scanning
Yvette L. Kasamon, Richard L. Wahl, Harvey A. Ziessman, Amanda L. Blackford, Steven N. Goodman, Caroline A. Fidyk, Kathryn M. Rogers, Javier Bolaños-Meade, Michael J. Borowitz, Richard F. Ambinder, RiVolume:
15
Year:
2009
Language:
english
Pages:
249
DOI:
10.1016/j.bbmt.2008.11.026
File:
PDF, 285 KB
english, 2009